Novozymes’ Post

Welcome to the era of biosolutions. Welcome to Novonesis. The proposed combination of Chr. Hansen and Novozymes is now successfully completed. Novonesis is a world-leading biosolutions partner for better business, healthier lives and a healthier planet. The combined company brings together 10,000 employees worldwide and expertise that spans more than 30 different industries. Our CEO Ester Baiget says: “Novonesis combines our joint strengths and the wonders of biology, and we are set to lead a new era of biosolutions. We will innovate and develop transformative biosolutions that improve the way we all produce, consume and live. And we have gathered the brightest minds and together with my 10,000 colleagues, we will unlock the limitless potential of biosolutions.” Cees de Jong, our Chair of the Board of Directors, adds his perspective: “I am pleased to witness the realization of the Novozymes and Chr. Hansen combination, creating a true global biosolutions leader. We will continue to create powerful biosolutions for our customers and partners based on our more than 100 years of innovation and application expertise. Together, we will serve as a growth partner to our customers; a value creator to our shareholders; and a company that has a significant, positive impact on society and the planet. Novonesis builds on a shared heritage of sustainability leadership and will keep leading the way.” Learn more in the press release here: https://lnkd.in/dNKhHu66 Follow Novonesis to keep updated on our future journey as a new company. #novonesis #newbeginning #biosolutions

Welcome to the era of biosolutions. Welcome to Novonesis.     The proposed combination of Novozymes and Chr. Hansen is now successfully completed. Novonesis is a world-leading biosolutions partner for better business, healthier lives, and a healthier planet. The combined company brings together 10,000 employees worldwide and expertise that spans more than 30 different industries.  Our CEO Ester Baiget says: “Novonesis combines our joint strengths and the wonders of biology, and we are set to lead a new era of biosolutions. We will innovate and develop transformative biosolutions that improve the way we all produce, consume and live. And we have gathered the brightest minds and together with my 10,000 colleagues, we will unlock the limitless potential of biosolutions.”     Cees de Jong, our Chair of the Board of Directors, adds his perspective: “I am pleased to witness the realization of the Novozymes and Chr. Hansen combination, creating a true global biosolutions leader. We will continue to create powerful biosolutions for our customers and partners based on our more than 100 years of innovation and application expertise. Together, we will serve as a growth partner to our customers; a value creator to our shareholders; and a company that has a significant, positive impact on society and the planet. Novonesis builds on a shared heritage of sustainability leadership and will keep leading the way.”    Learn more in this press release: https://lnkd.in/dNKhHu66   #novonesis #newbeginning #biosolutions  

One of the most exciting parts of my job is getting to showcase the work of those companies that are leading the advancement of innovative medicine, from Poland to the rest of the world. Such is the case of Molecure, a true beacon of the Polish biotechnology sector's potential to become a driver of growth for the national economy. Thank you Marcin Szumowski for taking the time to share your valuable insights with Executive Forecast. #RoadmapToSustainableHealthcare #Poland2024 #IndustryInsights

🎙️ Molecure's CEO, Marcin Szumowski, recently had an interview with Executive Forecast, where he discussed #Molecure's pivotal role in revolutionizing the healthcare sector in Poland. The conversation delves into our pioneering initiatives and the potential impact on healthcare globally 🌍💊   👉 Dive deeper into the interview with George Spirakis and Mónica Vargas Whittle: https://lnkd.in/dP8U5rA7    #HealthcareInnovation #Biotechnology #ExecutiveForecast

Join our Syneos Health Consulting team at JPM's Biotech Showcase next week in this panel discussion to learn more about how to invest for success in today's challenging environment!

🌱 Spring into Action this Equinox with Scale Biosciences! Just like the natural world, we're gearing up for growth and renewal! With new products sprouting, collaborations blossoming, and events in full bloom, this season promises to be one of innovation and discovery. Let's cultivate success together! #SingleCellSpring #singlecell #vernalequinox What cellular innovations are you hoping to discover this spring?

💡 Is it possible to scale up the european #biomanufacturing capacities while minimizing their environmental footprint? Come listen to the experts insights at #BIOSPAIN2023! ➡️ Biomanufacturing is a key element for the future of Europe. While it needs to scale up its capacities and performance, it also has to become more #sustainable. As an attempt to put some light on this topic, #Biocat will be sponsoring a panel discussion at Biospain (26 – 28 September, Barcelona).   📆 26/09 🕓10:15-11 a.m. Regulatory and reimbursement pathways, new approaches to investment, upskilling and reskilling workforce and adoption of sustainable solutions are some of the topics that will be discussed in this engaging round table.   Attendees will have the chance to listen to and spoke to: 🗣️ Nerea García, Site Director at Reig Jofre 🗣️ Hilary Stiss, Senior Manager for International Affairs, Biotechnology Innovation Organization 🗣️ Sara Secall, Partner at Inveready 🗣️ Claire Skentelbery, Director general EuropaBio - the European Association for Bioindustries and member of HERA Joint Industrial Cooperation Forum (JICF) 🗣️ Dámaso Molero Sánchez, CEO 3P Biopharmaceuticals   The discussion will be moderated by Anaïs Le Corvec Council of European BioRegions - CEBR and member of HERA Joint Industrial Cooperation Forum (JICF)   👉 https://ow.ly/Hfz850PLYME See you there!   #WeAreBiotech

SFBN Feed: Insights from new CEOs: Rachael McKinney, greater Sacramento market president, Sutter Health https://lnkd.in/gXRwbcDB Heading into a new year, new leaders are stepping up in the Sacramento region. One of those is Rachael McKinney, greater Sacramento market president for Sutter Health. Click here to view original post #BayArea #SanFrancisco #Biotech #Lifescience #News

Marcia da Silva Pinto, PhD, senior technical & product manager at Evolva, Lallemand Group, talks to Personal Care Insights about the synergies taking place at Lallemand since the acquisition of Evolva late last year. We also discuss promising #innovations in #biotech with three key #ingredients from the newly combined portfolio. Watch the full video here 👉 https://lnkd.in/eK3a9xb2